Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.
Vertex Pharmaceuticals is an innovative powerhouse with a good stock to buy on the dip. You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have ...
Key Takeaways Eli Lilly shares could remain under the microscope on Wednesday after falling sharply Tuesday as the ...
The shares of pharmaceutical giant Eli Lilly (LLY) are falling 5% today after the company preannounced ...
Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...
Could Donald Trump make Eli Lilly stock a no-brainer buy in 2025? Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO. FDA ...
Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...
High Return on Equity: With a three-year average ROE of 101% and an ROE of 123% in the last year, the company has ...